Page 4 - Huddinge News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Gender differences explored: Cardiovascular health variances in women s lifespan

Women's cardiovascular disease risks and outcomes differ throughout the lifespan from those of men, according to a collection of studies devoted to cardiovascular medicine research focused on women of all ages, published today in a special "spotlight" issue of the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.

United statesNorth carolinaNoord hollandNew yorkLa jollaSan diegoDuke universityLos angelesUniversity of southern californiaJian zhangLivg kvalvikAudreyl blewerSimona saccoAxelc carlssonKarolinska institutetLuise maldonado

Can GLP-1 Agonists Reduce Risk for Severe Liver Disease?

GLP-1 agonists could be a treatment option to reduce the risk for major adverse liver outcomes in adults with type 2 diabetes and chronic liver disease.

United statesKarolinska institutetAxel westerJamile wakim flemingDepartment of medicineMedscape medicalMetabolic steatosisCleveland clinicDiabetes mellitus type 2Iabetes mellitus type iiType 2 diabetesYpe 2 dmBiliary diseaseAllbladder diseaseLiver diseaseHepatic impairment

Barings acquires Swedish resi development project

Barings has acquired a 264-home development opportunity in Stockholm from Innovation Properties on behalf of a private insurance client. The parties agreed not to disclose the.

Gunther deutschAndreas norbergSweden housing authorityInnovation propertiesStockholm countryHousing authorityManaging directorBarings real estateEuropean transactionsInnovation propertiesManaging directorBarings real estateGunther deutschEuropean transactionsAndreas norbergHousing authority

Scientists Discover New Life-Saving Benefit of Ozempic and Semaglutide

A nationwide study conducted by the Karolinska Institutet in Sweden, published in the journal Gut, indicates that the use of Ozempic and similar GLP1 agonists is linked to a lower likelihood of cirrhosis and liver cancer in individuals with type 2 diabetes and chronic liver disease. GLP1 agonists

Axel westerHannes hagstrAnthonya matthewsAstra zenecaKarolinska institutetYing shangSwedish cancer societySwedish research councilNovo nordiskKarolinska university hospitalDepartment of medicineHuman liver pain diseaseEmilie toresson gripRegion stockholmSwedish cancer

Ozempic And Similar Drugs Reveal New Life-saving Benefits, Study Finds - ARAB TIMES

Ozempic And Similar Drugs Reveal New Life-saving Benefits, Study Finds - ARAB TIMES
arabtimesonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from arabtimesonline.com Daily Mail and Mail on Sunday newspapers.

Ying shangHannes hagstrAnthonya matthewsKarolinska institutetAxel westerDepartment of medicineKarolinska university hospitalEmilie toresson grip